David Bruyette, DVM, DACVIM (SAIM)

Chief Medical Officer
Anivive Lifesciences
Long Beach, California, United States

TBD

Disclosure information not submitted.

Presentation(s):

• The Science Behind SINE Class Drugs: Novel Small Molecules for Oncology

  On Demand